183 related articles for article (PubMed ID: 26142685)
1. Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration.
Denimal D; Pais de Barros JP; Petit JM; Bouillet B; Vergès B; Duvillard L
Atherosclerosis; 2015 Aug; 241(2):752-60. PubMed ID: 26142685
[TBL] [Abstract][Full Text] [Related]
2. Major changes in the sphingophospholipidome of HDL in non-diabetic patients with metabolic syndrome.
Denimal D; Nguyen A; Pais de Barros JP; Bouillet B; Petit JM; Vergès B; Duvillard L
Atherosclerosis; 2016 Mar; 246():106-14. PubMed ID: 26773402
[TBL] [Abstract][Full Text] [Related]
3. Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.
Sutter I; Velagapudi S; Othman A; Riwanto M; Manz J; Rohrer L; Rentsch K; Hornemann T; Landmesser U; von Eckardstein A
Atherosclerosis; 2015 Aug; 241(2):539-46. PubMed ID: 26093887
[TBL] [Abstract][Full Text] [Related]
4. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.
Camont L; Lhomme M; Rached F; Le Goff W; Nègre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Chapman MJ; Kontush A
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2715-23. PubMed ID: 24092747
[TBL] [Abstract][Full Text] [Related]
5. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.
Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702
[TBL] [Abstract][Full Text] [Related]
6. [Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes].
Bulum T; Duvnjak L; Prkacin I
Acta Med Croatica; 2011; 65(3):243-50. PubMed ID: 22359892
[TBL] [Abstract][Full Text] [Related]
7. Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities.
Denimal D; Benanaya S; Monier S; Simoneau I; Pais de Barros JP; Le Goff W; Bouillet B; Vergès B; Duvillard L
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3816-e3823. PubMed ID: 35647758
[TBL] [Abstract][Full Text] [Related]
8. S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease.
Argraves KM; Sethi AA; Gazzolo PJ; Wilkerson BA; Remaley AT; Tybjaerg-Hansen A; Nordestgaard BG; Yeatts SD; Nicholas KS; Barth JL; Argraves WS
Lipids Health Dis; 2011 May; 10():70. PubMed ID: 21554699
[TBL] [Abstract][Full Text] [Related]
9. High density lipoprotein changes during treatment of diabetic ketoacidosis.
Joven J; Rubiés-Prat J; de la Figuera M; Valdés M; Villabona CM; Chacón P; Masdeu S
Diabete Metab; 1985 Apr; 11(2):102-5. PubMed ID: 3924672
[TBL] [Abstract][Full Text] [Related]
10. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
[TBL] [Abstract][Full Text] [Related]
11. [Levels of HDL cholesterol and the HDL2 and HDL3 subfractions in newly detected type 2 diabetes].
Brunová J; Válek J; Grafnetter D; Karasová L
Vnitr Lek; 1989 Mar; 35(3):292-8. PubMed ID: 2734999
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
[TBL] [Abstract][Full Text] [Related]
13. Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
Sattler K; Gräler M; Keul P; Weske S; Reimann CM; Jindrová H; Kleinbongard P; Sabbadini R; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
J Am Coll Cardiol; 2015 Sep; 66(13):1470-85. PubMed ID: 26403344
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.
Frias MA; Thomas A; Brulhart-Meynet MC; Kövamees O; Pernow J; Eriksson M; Angelin B; James RW; Brinck JW
Eur J Clin Invest; 2017 Jan; 47(1):38-43. PubMed ID: 27861771
[TBL] [Abstract][Full Text] [Related]
15. [Changes in HDL subfractions in patients with type I diabetes mellitus before and after metabolic control].
Pacifico A; Cherchi GM; Baggi MA; Deiana MG; Maioli M
Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1618-24. PubMed ID: 6365116
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a Measurement System for Sphingolipids in the Cerebrospinal Fluid Based on Liquid Chromatography-Tandem Mass Spectrometry, and Its Application in the Diagnosis of Carcinomatous Meningitis.
Sakai E; Kurano M; Morita Y; Aoki J; Yatomi Y
J Appl Lab Med; 2020 Jul; 5(4):656-670. PubMed ID: 32407524
[TBL] [Abstract][Full Text] [Related]
17. Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry.
Sullards MC; Merrill AH
Sci STKE; 2001 Jan; 2001(67):pl1. PubMed ID: 11752637
[TBL] [Abstract][Full Text] [Related]
18. Impaired antioxidant action of high density lipoprotein in patients with type 1 diabetes with normoalbuminuria and microalbuminuria.
Sampaio E; Barbosa DS; Mazzuco TL; Nunes VS; Passarelli M; Nakandakare ER; Carrilho AJ
Diabetes Res Clin Pract; 2013 Mar; 99(3):321-6. PubMed ID: 23394721
[TBL] [Abstract][Full Text] [Related]
19. HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate.
Lee MH; Hammad SM; Semler AJ; Luttrell LM; Lopes-Virella MF; Klein RL
J Lipid Res; 2010 Sep; 51(9):2619-28. PubMed ID: 20522601
[TBL] [Abstract][Full Text] [Related]
20. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
